Availability of the 2023 Annual Financial Report
17 October 2023
LEI: 213800J4UVB5OWG8VX82
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
Availability of 2023 Annual Report and Accounts
The 2023 Annual Report and Accounts are now available to view at www.dechra.com.
The 2023 Annual Report and Accounts are scheduled to be mailed to registered shareholders of the Company on 30 October 2023.
In accordance with Listing Rule 9.6.1 a copy of the 2023 Annual Report and Accounts will be submitted to the National Storage Mechanism and will be available for viewing shortly after posting.
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. For more information please visit: www.dechra.com
Trademarks
Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
COMPANIES COVERED:
Latest directors dealings
- 16 hours ago Cerillion
- 18 hours ago Associated British Foods
- 18 hours ago B&M European Value Retail S.A. (DI)
- 18 hours ago B&M European Value Retail S.A. (DI)
- 18 hours ago Haleon